Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › CGEN
SILVERARC CAPITAL MANAGEMENT, LLC position in CGEN
COMPUGEN LTD · Health Care
SILVERARC CAPITAL MANAGEMENT, LLC reported holding 3,586,785 shares of CGEN (COMPUGEN LTD) in its Q3 2026 13F filing — a position valued at US$8.5M, representing 1.09% of its reported portfolio and ranking #28 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed CGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SILVERARC CAPITAL MANAGEMENT, LLC's CGEN position evolved
SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in CGEN in Q3 2023 at 350,188 shares (US$326K). The position peaked in Q3 2026 at 3,586,785 shares, worth US$8.5M. Across 13 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 9 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,586,785 shares valued at US$8.5M — an increase of 402,528 shares quarter over quarter.. Notable position changes include a 168% increase in Q4 2023 (shares rose 30% over the following quarter), a 50% increase in Q2 2024 (shares rose 8% over the following quarter), a 78% increase in Q1 2025 (shares rose 22% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 350.19K | $325.68K | New |
| Q4 2023 | 940.00K | $1.86M | Add |
| Q1 2024 | 1.00M | $2.58M | Add |
| Q2 2024 | 1.50M | $2.52M | Add |
| Q3 2024 | 1.50M | $2.72M | Hold |
| Q4 2024 | 1.62M | $2.49M | Add |
| Q1 2025 | 2.90M | $4.23M | Add |
| Q2 2025 | 3.03M | $5.40M | Add |
| Q3 2025 | 3.31M | $4.87M | Add |
| Q4 2025 | 3.48M | $5.32M | Add |
| Q1 2026 | 3.32M | $7.06M | Reduce |
| Q2 2026 | 3.18M | $6.81M | Reduce |
| Q3 2026 | 3.59M | $8.54M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CGEN and 13F data
CGEN (COMPUGEN LTD) is a Health Care company. 25 other funds we track also report a position in CGEN — the largest reported positions include Taylor Frigon Capital Management LLC (US$1.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CGEN
- Taylor Frigon Capital Management LLC 816.25K sh · $1.94M · Q3 2026
More on SILVERARC CAPITAL MANAGEMENT, LLC
FAQ
How long has SILVERARC CAPITAL MANAGEMENT, LLC held CGEN?
SILVERARC CAPITAL MANAGEMENT, LLC has disclosed CGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in CGEN?
As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 3.59M shares of CGEN (COMPUGEN LTD), valued at $8.54M, representing 1.09% of its reported portfolio and ranking #28.
Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling CGEN?
In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in CGEN. The position peaked in Q3 2026 at 3.59M shares.
Which other funds hold CGEN?
Other major institutional holders of CGEN include Taylor Frigon Capital Management LLC, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.